-
公开(公告)号:US10076503B2
公开(公告)日:2018-09-18
申请号:US15310351
申请日:2015-05-12
Applicant: SUNOVION PHARMACEUTICALS INC.
Inventor: Antony D. Loebel , Kenneth S. Koblan
IPC: A61K31/135 , A61K9/00
CPC classification number: A61K31/135 , A61K9/0053 , A61K9/4858
Abstract: Dosage forms and treatment regimens employing dasotraline for treating Attention Deficit Hyperactivity Disorder (ADHD) are disclosed. The compositions described herein exhibit no abuse potential.